Robuta

https://www.aidsmap.com/news/apr-2014/who-recommends-global-use-newest-hepatitis-c-drugs-urges-price-reductions
The World Health Organization has issued global treatment guidelines for hepatitis C, strongly recommending the use of the new direct-acting antivirals...
hepatitis crecommendsglobalusenewest
https://www.aidsmap.com/?content-type%5B0%5D=editors-picks&topic%5B0%5D=46&page=1
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/news/feb-2009/men-becoming-visible-more-light-shed-men-who-have-sex-men-africa-and-india
The majority of men who have sex with men (MSM) in three different African countries and in Tamil Nadu State in India also have sex with women, according to...
menbecomingvisiblelightshed
https://www.aidsmap.com/?content-type%5B0%5D=news&content-type%5B1%5D=editors-picks&country%5B0%5D=11838&page=3
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/archive?content-type%5B%5D=editors-picks&topic%5B%5D=162
aidsmap
https://www.aidsmap.com/news/mar-2014/abbvie-3d-combination-cures-99-genotype-1b-hepatitis-c
A 12-week triple combination of direct-acting antivirals developed by AbbVie cured at least 99% of previously untreated people with genotype 1 hepatitis C...
hepatitis cabbviecombinationcuresgenotype
https://www.aidsmap.com/about-hiv/arv-background-information/dovato
Dovato is a two-drug combination of the HIV integrase inhibitor dolutegravir and the HIV nucleoside reverse transcriptase inhibitor lamivudine.
dovatoaidsmap
https://www.aidsmap.com/archive?content-type%5B%5D=news&topic%5B%5D=70
aidsmap
https://www.aidsmap.com/archive/all/pregnancy-children-young-people?page=0
aidsmap
https://www.aidsmap.com/?content-type%5B0%5D=news&content-type%5B1%5D=editors-picks&country%5B0%5D=10466&page=7
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/archive/news/hiv-treatment?page=6
aidsmap
https://www.aidsmap.com/archive/all/testing-health-monitoring/hiv-testing-policies-guidelines
aidsmap
https://www.aidsmap.com/archive/author/vicky-crompton
aidsmap
https://www.aidsmap.com/archive/editors-picks/hepatitis-hiv?page=4
aidsmap
https://www.aidsmap.com/about-hiv/arv-factsheet/efavirenz
Efavirenz is a medication used to treat HIV. It was originally marketed under the brand name Sustiva, but generic versions are also available. It is taken in...
efavirenzaidsmap
https://www.aidsmap.com/news/aug-2006/us-led-war-drugs-inadvertently-fuelling-hiv-epidemic
An excessive reliance on drug law enforcement is the major barrier to stemming the tide of new HIV infections amongst injecting drug users (IDUs), Australian...
hiv epidemicusledwardrugs
https://www.aidsmap.com/?content-type%5B0%5D=news&topic%5B0%5D=141&page=1
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/?keyword=Women&page=229
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/about-hiv/arv-factsheet/doravirine
Doravirine is a medication used to treat HIV, marketed under the brand name Pifeltro. It is taken in combination with other antiretroviral drugs.
doravirineaidsmap
https://www.aidsmap.com/news/nov-2021/ugandan-traditional-healers-improve-access-hiv-testing
Ugandans in rural areas are four times more likely to access HIV testing when it is offered by a traditional healer according to a report in The Lancet Global...
hiv testingugandantraditionalhealersimprove
https://www.aidsmap.com/videos?topic%5B0%5D=149
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
videosaidsmap
https://www.aidsmap.com/about-hiv/arv-background-information/lenacapavir-sunlenca
Lenacapavir is the first HIV capsid inhibitor. Lenacapavir has been licensed in the United States, European Union and United Kingdom for the treatment of...
lenacapavirsunlencaaidsmap
https://www.aidsmap.com/archive/all/populations?page=8
aidsmap
https://www.aidsmap.com/archive/all/hepatitis-hiv?page=6
aidsmap
https://www.aidsmap.com/archive?content-type%5B%5D=editors-picks&topic%5B%5D=104
aidsmap
https://www.aidsmap.com/?content-type%5B0%5D=news&topic%5B0%5D=161&page=0
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/news/feb-2002/niacin-reduces-abdominal-fat-pilot-study
The vitamin niacin (B3, or nicotinic acid), already known for its cholesterol-lowering effects, may also reduce central or abdominal fat accumulation in...
abdominal fatpilot studyniacinreducesaidsmap
https://www.aidsmap.com/?content-type%5B0%5D=editors-picks&topic%5B0%5D=47&page=5
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/news/mar-2009/low-hdl-cholesterol-linked-cardiovascular-disease-people-hiv
Lower levels of beneficial high-density lipoprotein (HDL) cholesterol - but not of harmful low-density lipoprotein (LDL) - were associated with cardiovascular...
low hdl cholesterolcardiovascular diseaselinkedpeople
https://www.aidsmap.com/news/mar-2010/kinsey-institute-study-finds-no-consensus-definitions-had-sex
When people say they "had sex", what transpired is anyone's guess. A new study from the Kinsey Institute at Indiana University found that no uniform consensus...
kinsey institutestudy findsconsensusdefinitions
https://www.aidsmap.com/news/may-2022/what-are-mens-sexual-and-reproductive-health-needs
Share-Net Netherlands, the Netherlands Network on Sexual and Reproductive Health and Rights, recently published a position paper on men's sexual and...
reproductive healthmensexualneedsaidsmap
https://www.aidsmap.com/news/jul-2015/young-woman-stays-undetectable-twelve-years-treatment-after-early-hiv-therapy
The 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) heard today of a case where a young woman, who was...
young womantwelve yearsstaysundetectabletreatment
https://www.aidsmap.com/news/mar-2007/croi-tenofovir-causing-kidney-problems
Tenofovir (Viread) has been associated with kidney (renal) toxicity in certain cases, although this has proven to be nearly always mild, rare, and reversible....
kidney problemscroitenofovircausingaidsmap
https://www.aidsmap.com/?content-type%5B0%5D=news&topic%5B0%5D=161&page=2
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/?content-type%5B0%5D=news&content-type%5B1%5D=editors-picks&country%5B0%5D=12292&page=5
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/archive/all/populations?page=6
aidsmap
https://www.aidsmap.com/?content-type%5B0%5D=news&content-type%5B1%5D=editors-picks&country%5B0%5D=11690&page=6
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/about-hiv/cases-hiv-cure
Cases of HIV cure are exceptional, though there are also some cases of long-term control of HIV without having to take treatment.
hiv curecasesaidsmap
https://www.aidsmap.com/about-hiv/travel-insurance-people-hiv
Many travel insurance providers will now cover people with HIV, but this may incur an additional cost. This page reflects the personal finance market in the UK.
travel insurancepeoplehivaidsmap
https://www.aidsmap.com/about-hiv/basics/hiv-and-immune-system
Easy-to-read and illustrated information on HIV and the immune system.
immune systemhivaidsmap
https://www.aidsmap.com/archive/all/health-services-systems?page=1
aidsmap
https://www.aidsmap.com/news/jul-2020/least-28000-women-united-states-have-started-prep
A study of prescriptions for Truvada (tenofovir disoproxil fumarate/emtricitabine, often abbreviated to TDF/FTC) in the USA has found that its use as PrEP by...
united statesleastwomen
https://www.aidsmap.com/news/apr-2014/bms-combination-cures-90-genotype-1b-hepatitis-c-24-weeks
A combination of two direct-acting antivirals developed by Bristol-Myers Squibb (BMS) cured 90% of previously untreated people with genotype 1b hepatitis C...
hepatitis cbmscombinationcuresgenotype
https://www.aidsmap.com/news/sep-2004/slow-real-progress-antibodies-against-hiv
There is wide consensus among AIDS vaccine researchers that we need an HIV vaccine to induce high levels of neutralising antibodies against a wide range of HIV...
real progressslowantibodieshivaidsmap
https://www.aidsmap.com/conferences/eacs-standard-care-hiv-coinfections-europe-2019
News and research from the Standard of Care for HIV & Coinfections in Europe meeting, which took place in Bucharest, Romania, from 30 to 31 January 2019. The...
eacsstandardcarehivcoinfections
https://www.aidsmap.com/videos?topic%5B0%5D=76
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
videosaidsmap
https://www.aidsmap.com/news/feb-2014/tb-hiv-news-44th-union-world-conference-lung-health
HIV-related tuberculosis (HIV-TB) received unprecedented attention at the 44th Union World Conference on Lung Health, held in Paris. This report will attempt...
hiv newsworld conferencetbunion
https://www.aidsmap.com/news/jul-2011/once-daily-elvitegravir-matches-raltegravir
The experimental HIV integrase inhibitor elvitegravir works as well as raltegravir (Isentress) for treatment-experienced people with extensive drug resistance,...
dailyelvitegravirmatchesraltegraviraidsmap
https://www.aidsmap.com/news/oct-2016/two-drug-hiv-therapy-just-effective-three-drug-therapy
Simplification of an antiretroviral treatment to a boosted protease inhibitor and the nucleoside analogue lamivudine (a dual regimen) is highly effective in...
hiv therapytwodrugeffectivethree
https://www.aidsmap.com/?content-type%5B0%5D=editors-picks&topic%5B0%5D=182&page=1
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/news/aug-2006/researchers-launch-hunt-people-who-control-hiv-without-drugs
An international appeal is underway to find people who are controlling HIV at very low viral load levels without any medication in order to learn how they...
researcherslaunchhuntpeoplecontrol
https://www.aidsmap.com/news/mar-2024/almost-two-thirds-new-hiv-cases-occur-outside-southern-and-eastern-africa
Almost two-thirds of new cases of HIV now occur outside countries with high HIV prevalence in southern and eastern Africa, according to an analysis of UNAIDS...
two thirdsalmostnewhivcases
https://www.aidsmap.com/news/mar-2021/hptn-083-injectable-prep-can-make-breakthrough-infections-hard-detect
A detailed analysis of results from the HPTN 083 PrEP study, which compared the efficacy of a two-monthly injection of the drug cabotegravir against daily oral...
hptninjectableprepmakebreakthrough
https://www.aidsmap.com/?content-type%5B0%5D=news&topic%5B0%5D=41&page=8
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/news/mar-2013/simeprevir-pushes-hcv-cure-rate-above-75-hivhcv-co-infection
Adding the new hepatitis C virus (HCV) protease inhibitor simeprevir (formerly TMC435) to pegylated interferon and ribavirin cures about three-quarters of...
cure ratesimeprevirpusheshcvhiv
https://www.aidsmap.com/archive/news-all/healthy-living?page=1
aidsmap
https://www.aidsmap.com/news/apr-2014/sofosbuvirledipasvir-produces-early-cure-100-people-hiv-and-hcv-co-infection
Treatment for 12 weeks with a co-formulation of sofosbuvir and ledipasvir led to sustained response for all participants with HIV and HCV co-infection who had...
sofosbuvirledipasvirproducesearlycure
https://www.aidsmap.com/news/nov-2021/has-another-woman-naturally-cleared-hiv
A second woman appears to have naturally eliminated HIV without a stem cell transplant and may be considered cured, according to a report in Annals of Internal...
another womannaturallyclearedhivaidsmap
https://www.aidsmap.com/news/feb-2024/answer-covid-19-severity-people-hiv-may-lie-gut
People with HIV who develop severe COVID-19 experience major changes in gut bacteria that persist for months after infection and may explain both the severity...
answercovidseveritypeoplehiv
https://www.aidsmap.com/news/jun-2019/antiretrovirals-do-not-cause-neurodevelopmental-harm-uninfected-infants
In the first five years of life the neurological development of HIV-exposed but uninfected infants, exposed to maternal antiretrovirals before and after birth...
antiretroviralscauseneurodevelopmentalharminfants
https://www.aidsmap.com/videos/dr-tristan-barber-and-jo-josh-talk-about-hiv-and-ageing
Dr Tristan Barber and Jo Josh talk about HIV and ageing, including the health prospects for people living with HIV, and give advice for people to stay healthy...
jo joshdrtristanbarbertalk
https://www.aidsmap.com/archive/editors-picks/pregnancy-children-young-people/conception
aidsmap
https://www.aidsmap.com/archive/editors-picks/health-problems-ageing/tuberculosis-hiv
aidsmap
https://www.aidsmap.com/news/jul-2023/switches-away-integrase-inhibitors-do-not-reverse-weight-gain-studies-find
Switching from an integrase inhibitor to another regimen did not reverse weight gain in two studies that tested alternative regimens, researchers reported at...
integrase inhibitorsweight gainswitchesawayreverse
https://www.aidsmap.com/archive/about-hiv/hiv-vaccine-cure-research/search-hiv-prevention-vaccine
aidsmap
https://www.aidsmap.com/news/apr-2014/abbvie-3-drug-combination-cures-92-96-hepatitis-c-patients-cirrhosis
The largest study of new direct-acting antivirals yet conducted in people with hepatitis C genotype 1 who have compensated cirrhosis has shown that it is...
drug combinationabbviecureshepatitis
https://www.aidsmap.com/?content-type%5B0%5D=editors-picks&topic%5B0%5D=32&page=1
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/news/oct-2021/fund-hiv-action-plan
It's almost 1000 days since the Government committed to ending new HIV transmissions by 2030 and we're still waiting for action. With the National AIDS Trust,...
action planfundhivaidsmap
https://www.aidsmap.com/?content-type%5B0%5D=news&topic%5B0%5D=52&page=5
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/news/mar-2020/hiv-cure-may-work-differently-women-and-men
Given sex differences in viral reservoir dynamics, the role of oestrogen in maintaining viral latency and subtle immunological differences between women and...
hiv curemayworkdifferentlywomen
https://www.aidsmap.com/news/nov-2013/daclatasvir-asunaprevir-cures-85-genotype-1b-hepatitis-c-patients-japanese-study
An interferon- and ribavirin-free oral regimen of daclatasvir plus asunaprevir taken for 24 weeks led to sustained virological response (SVR12) in 85% of...
hepatitis cdaclatasvirasunaprevircuresgenotype
https://www.aidsmap.com/news/mar-2006/debate-continues-over-interaction-between-ritonavir-boosted-atazanavir-and-antacids
Three letters published in the March edition of The Journal of Acquired Immune Deficiency Syndromes have illustrated that there is still considerable...
debatecontinuesinteractionritonavirboosted
https://www.aidsmap.com/news/jul-2017/medical-male-circumcision-hiv-has-benefits-women-too
South African women whose most recent sexual partner was circumcised are less likely to have HIV, suggesting that the voluntary medical male circumcision...
male circumcisionmedicalhivbenefitswomen
https://www.aidsmap.com/archive/all/prep?page=16
aidsmap
https://www.aidsmap.com/archive/news/health-problems-ageing/chemsex-recreational-drug-use
aidsmap
https://www.aidsmap.com/?content-type%5B0%5D=editors-picks&topic%5B0%5D=102&page=2
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/archive?content-type%5B0%5D=news&content-type%5B1%5D=editors-picks&country%5B0%5D=11921
aidsmap
https://www.aidsmap.com/news/jan-2016/xpert-mtbrif-testing-has-reduced-mdr-tb-treatment-delays-south-africa
Although the introduction of the Xpert MTB/RIF test for TB and drug-resistant TB has improved the time from clinic presentation to second-line treatment in...
mdr tbxpertmtbriftesting
https://www.aidsmap.com/news/may-2018/dolutegravir-may-cause-birth-defects-european-medicines-agency-warns
Regulatory agencies in the United States and European Union have warned that women with HIV who can become pregnant should not use the integrase inhibitor...
european medicines agencybirth defectsdolutegravirmaycause
https://www.aidsmap.com/?content-type%5B0%5D=news&topic%5B0%5D=161&page=1
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/archive/editors-picks/health-services-systems/epidemiology
aidsmap
https://www.aidsmap.com/news/jan-2016/mdr-tb-treatment-six-drugs-better-five
A regimen containing six drugs was more likely to cure multi-drug resistant tuberculosis (MDR-TB) than a regimen containing five drugs, a nine-country...
mdr tbtreatmentsixdrugsbetter
https://www.aidsmap.com/archive?content-type%5B%5D=news&topic%5B%5D=14480
aidsmap
https://www.aidsmap.com/archive/news-all/social-legal-issues?page=3
aidsmap
https://www.aidsmap.com/news/feb-2016/major-disparities-persist-lifetime-risk-hiv-diagnosis-us
The lifetime risk of being diagnosed with HIV in the US has decreased overall during the past decade, falling to 1 in 99, according to a study from the Centers...
lifetime riskhiv diagnosismajordisparitiespersist
https://www.aidsmap.com/conferences/aasld-2017
News and research from The Liver Meeting 2017, organised by the American Association for the Study of Liver Diseases (AASLD), which took place in Washington...
aasldaidsmap
https://www.aidsmap.com/news/feb-2007/croi-microbicide-failure-poses-more-questions-answers
The recent trial of the candidate microbicide cellulose sulphate (Ushercell) was closed because of 35 seroconversions amongst trial subjects, all of which...
croimicrobicidefailureposesquestions
https://www.aidsmap.com/news/mar-2024/progress-reducing-new-hiv-diagnoses-much-slower-black-men-us
Lifetime risk of acquiring HIV has decreased for Black gay and bisexual men in the US, from 1 in 2 from 2010 to 2014 to 1 in 3 from 2017 to 2021, according to...
progressreducingnewhivdiagnoses
https://www.aidsmap.com/archive/news/testing-health-monitoring?page=8
aidsmap
https://www.aidsmap.com/news/jan-2018/smoking-reduces-survival-after-liver-cancer-diagnosis-people-viral-hepatitis
People with viral hepatitis who smoked were three times more likely to die after being diagnosed with liver cancer (hepatocellular carcinoma, HCC), according...
liver cancersmokingreducessurvivaldiagnosis
https://www.aidsmap.com/news/jul-2009/new-guidance-healthcare-hiv-positive-asylum-seekers-detention
The National AIDS Trust (NAT) and the British HIV Association (BHIVA) have issued best practice guidance to support asylum seekers living with HIV while they...
new guidancehiv positiveasylum seekershealthcare
https://www.aidsmap.com/news/apr-2024/cryptococcal-meningitis-persists-botswana-despite-high-antiretroviral-coverage
A study of cryptococcal meningitis incidence in people with HIV in Botswana shows that incidence has halved since 2015 and that the decline is correlated to...
cryptococcal meningitispersistsbotswanadespitehigh
https://www.aidsmap.com/about-hiv/managing-multiple-health-conditions
Many people living with HIV have other health conditions as well.
multiple health conditionsmanagingaidsmap
https://www.aidsmap.com/news/jun-2010/south-african-gold-mines-tb-factory-activist-claims
The gold-mining sector came under heavy criticism from clinicians, ex-miners, advocacy groups and the Minister of Health for the tuberculosis crisis it faces...
south african goldminestbfactoryactivist
https://www.aidsmap.com/videos/susan-cole-talks-about-weight-gain-and-hiv-treatment
Starting anti-HIV treatment improves your health, suppresses HIV and helps to strengthen your immune system. But treatment can also cause side effects,...
susan coleweight gainhiv treatmenttalksaidsmap
https://www.aidsmap.com/?content-type=news&topic=58&page=0
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/?content-type%5B0%5D=editors-picks&topic%5B0%5D=14503&page=1
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/archive/editors-picks/health-services-systems/palliative-care
aidsmap
https://www.aidsmap.com/?content-type%5B0%5D=news&content-type%5B1%5D=editors-picks&country%5B0%5D=11838&page=351
We work to change lives by sharing information about HIV & AIDS. We believe independent, clear and accurate information is vital
aidsmap
https://www.aidsmap.com/news/aug-2005/ias-rifampin-tb-treatment-does-not-reduce-response-nnrtis-south-africans-report
Using rifampin-based therapy alongside a triple antiretroviral regimen that contains drugs from the NNRTI class (either nevirapine or efavirenz) does not...
tb treatmentiasrifampinreduceresponse